Effects of Sishen Pills and its separated prescriptions on human intestinal flora based on in vitro fermentation model.
10.19540/j.cnki.cjcmm.20250401.401
- Author:
Jia-Yang XI
1
;
Qi-Qi WANG
1
;
Xue CHENG
2
;
Hui XIA
2
;
Lu CAO
2
;
Yue-Hao XIE
1
;
Tian-Xiang ZHU
2
;
Ming-Zhu YIN
2
Author Information
1. College of Basic Medical Sciences,Hubei University of Chinese Medicine Wuhan 430065,China.
2. College of Basic Medical Sciences,Hubei University of Chinese Medicine Wuhan 430065,China Hubei Shizhen Laboratory Wuhan 430061,China.
- Publication Type:Journal Article
- Keywords:
Ershen Pills;
Sishen Pills;
Wuweizi Powder;
in vitro fermentation;
intestinal flora
- MeSH:
Humans;
Gastrointestinal Microbiome/drug effects*;
Drugs, Chinese Herbal/chemistry*;
Fermentation/drug effects*;
Bacteria/drug effects*;
Chromatography, High Pressure Liquid;
Tandem Mass Spectrometry;
Intestines/microbiology*
- From:
China Journal of Chinese Materia Medica
2025;50(11):3137-3146
- CountryChina
- Language:Chinese
-
Abstract:
Sishen Pills and its separated prescriptions are classic prescriptions of traditional Chinese medicine to treat intestinal diseases. In this study, a high-performance liquid chromatography-electrospray ionization tandem mass spectrometry(HPLC-ESI-MS/MS) technology was used to identify the components of Sishen Pills, Ershen Pills, and Wuweizi Powder. The positive and negative ion sources of electrospray ionization were simultaneously collected by mass spectrometry. A total of 11 effective components were detected in Sishen Pills, with four effective components detected in Ershen Pills and eight effective components detected in Wuweizi Powder, respectively. To explore the effects of Sishen Pills and its separated prescriptions on the human intestinal flora, an in vitro anaerobic fermentation model was established, and the human intestinal flora was incubated with Sishen Pills, Ershen Pills, and Wuweizi Powder in vitro. The 16S rDNA sequencing technology was used to analyze the changes in the intestinal flora. The results showed that compared with the control group, Sishen Pills, and its separated prescriptions could decrease the intestinal flora abundance and increase the Shannon index after fermentation. The abundance of Bifidobacterium was significantly increased in the Sishen Pills and Ershen Pills groups. However, the abundance of Lactobacillus, Weissella, and Pediococcus was significantly increased in the Wuweizi Powder group. After fermentation for 12 h, the pH of the fermentation solution of three kinds of liquids with feces gradually decreased and was lower than that of the control group. The decreasing amplitude in the Wuweizi Powder group was the most obvious. The single-bacteria fermentation experiments further confirmed that Sishen Pills and Wuweizi Powder had inhibitory effects on Escherichia coli, Staphylococcus aureus, and Enterococcus faecalis, and the antibacterial activity of Wuweizi Powder was stronger than that of Sishen Pills. Both Sishen Pills and Ershen Pills could promote the growth of Lactobacillus brevis, and Ershen Pills could promote the growth of Bifidobacterium adolescentis. This study provided a more sufficient theoretical basis for the clinical application of Sishen Pills and its separated prescriptions.
